Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay

Journal of Virological Methods

Volumn 187, Issue 1, 2013, Pages 72-78

  Sunwoo, Hoon H ^a   Palaniyappan, Arivazhagan ^a   Ganguly, Advaita ^a   Bhatnagar, Pravin K ^a   Das, Dipankar ^a   El Kadi, Ayman O S ^a   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bi specific monoclonal antibodies; ELISA; Quadroma; SARS CoV; Spike protein

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; VIRUS SPIKE PROTEIN; VIRUS SPIKE PROTEIN S1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYBRIDOMA; LIMIT OF DETECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE STUDY; SARS CORONAVIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NUCLEOCAPSID PROTEINS; RECOMBINANT PROTEINS; SARS VIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

SARS CORONAVIRUS;

EID: 84871734775     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.09.006     Document Type: Article

References (48)

1. Babcock G.J., Esshaki D.J., Thomas W.D., Ambrosino D.M. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. Journal of Virology 2004, 78:4552-4560.
2. Balboni A., Battilani M., Prosperi S. The SARS-like coronaviruses: the role of bats and evolutionary relationships with SARS coronavirus. New Microbiologica 2012, 35:1-16.
3. Berry J.D., Hay K., Rini J.M., Yu M., Want L., Plummer F.A., Corbett C.R., Andonov A. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology. MAbs 2010, 2:53-66.
4. Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. Journal of Virology 2003, 77:8801-8811.
5. Colman P.M., Lawrence M.C. The structural biology of type I viral membrane fusion. Nature Reviews Molecular Cell Biology 2003, 4:309-319.
6. Gallagher T.M., Buchmeier M.J. Coronavirus spike proteins in viral entry and pathogenesis. Virology 2001, 279:371-374.
7. Giménez L.G., Rojas J., Rojas A., Mendoza J., Camacho A.G. Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody. Clinical and Vaccine Immunology 2009, 16:241-245.
8. He Q., Du Q., Lau S., Manopo I., Lu L., Chan S.W., Fenner B.J., Kwang J. Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. Journal of Virological Methods 2005, 127:46-53.
9. He Y., Li J., Heck S., Lustigman S., Jiang S. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design. Journal of Virology 2006, 80:5757-5767.
10. Ho T.Y., Wu S.L., Cheng S.E., Wei Y.C., Huang S.P., Hsiang C.Y. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. Biochemical and Biophysical Research Communications 2004, 313:938-947.
11. Hofmann H., Geier M., Marzi A., Krumbiegel M., Peipp M., Fey G.H., Gramberg T., Pohlmann S. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochemical and Biophysical Research Communications 2004, 319:1216-1221.
12. Holmes K.V. SARS-associated coronavirus. New England Journal of Medicine 2003, 348:1948-1951.
13. Huanga Y., Zhaoa R., Jia Luoa J., Xionga S., Shangguana D., Zhanga H., Liua G., Chena Y. Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV. Journal of Molecular Recognition 2008, 21:122-131.
14. Huang I.C., Bosch B.J., Li F., Li W., Lee K.H., Ghiran S., Vasilieva N., Dermody T.S., Harrison S.C., Dormitzer P.R., Farzan M., Rottier P.J., Choe H. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. Journal of Biological Chemistry 2006, 281:3198-3203.
15. Kammila S., Das D., Bhatnagar P.K., Sunwoo H.H., Zayas-Zamora G., King M., Suresh M.R. A rapid point of care immunoswab assay for SARS-CoV detection. Journal of Virological Methods 2008, 152:77-84.
16. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
17. Krokhin O., Li Y., Andonov A., Feldmann H., Flick R., Jones S., Stroeher U., Bastien N., Dasuri K.V., Cheng K., Simonsen J.N., Perreault H., Wilkins J., Ens W., Plummer F., Standing K.G. Mass spectrometric characterization of proteins from the SARS virus: a preliminary report. Molecular and Cellular Proteomics 2003, 2:346-356.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. Lau S.K., Woo P.C., Li K.S., Huang Y., Tsoi H.W., Wong B.H., Wong S.S., Leung S.Y., Chan K.H., Yuen K.Y. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:14040-14045.
20. Li G., Chen X., Xu A. Profile of specific antibodies to the SARS-associated coronavirus. New England Journal of Medicine 2003, 349:508-509.
21. Li F., Li W., Farzan M., Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005, 309:1864-1868.
22. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426:450-454.
23. Li C.K., Wu H., Yan H., Ma S., Wang L., Zhang M., Tang X., Temperton N.J., Weiss R.A., Brenchley J.M., Douek D.C., Mongkolsapaya J., Tran B.H., Lin C.L., Screaton G.R., Hou J.L., McMichael A.J., Xu X.N. T cell responses to whole SARS coronavirus in humans. Journal of Immunology 2008, 181:5490-5500.
24. Lu X., Chen Y., Bai B., Hu H., Tao L., Yang J., Chen J., Chen Z., Hu Z., Wang H. Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice. Immunology 2007, 122:496-502.
25. Lu L., Manopo I., Leung B.P., Chng H.H., Ling A.E., Chee L.L., Ooi E.E., Chan S.W., Kwang J. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology 2004, 42:1570-1576.
26. Marra M.A. The genome sequence of the SARS-associated coronavirus. Science 2003, 300:1399-1404.
27. Palaniyappan A., Das D., Kammila S., Suresh M.R., Sunwoo H.H. Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y. Poultry Science 2012, 91:636-642.
28. Peiris J.S., Poon L.L. Detection of SARS coronavirus. Methods in Molecular Biology 2011, 665:369-382.
29. Poon L.L., Chan K.H., Peiris J.S. Crouching tiger, hidden dragon: The laboratory diagnosis of severe acute respiratory syndrome. Clinical Infectious Diseases 2004, 38:297-299.
30. Poon L.L., Chan K.H., Wong O.K., Yam W.C., Yuen K.Y., Guan Y., Lo Y.M., Peiris J.S. Early diagnosis of SARS coronavirus infection by real time RT-PCR. Journal of Clinical Virology 2003, 28:233-238.
31. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P. Characterization of novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300:1394-1399.
32. Sainz B., Rausch J.M., Gallaher W.R., Garry R.F., Wimley W.C. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry. Biochemistry 2005, 44:947-958.
33. Siu Y.L., Teoh K.T., Lo J., Chan C.M., Kien F., Escriou N., Tsao S.W., Nicholls J.M., Altmeyer R., Peiris J.S., Bruzzone R., Nal B. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. Journal of Virology 2008, 82:11318-11330.
34. Spiga O., Bernini A., Ciutti A., Chiellini S., Menciassi N., Finetti F., Causarono V., Anselmi F., Prischi F., Niccolai N. Molecular modeling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochemical and Biophysical Research Communications 2003, 310:78-83.
35. Sui J., Li W., Murakami A., Tamin A., Matthews L.J., Wong S.K., Moore M.J., Tallarico A.S., Olurinde M., Choe H., Anderson L.J., Bellini W.J., Farzan M., Marasco W.A. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2536-2541.
36. Tan Y.J., Goh P.Y., Fielding B.C., Shen S., Chou C.F., Fu J.L., Leong H.N., Leo Y.S., Ooi E.E., Ling A.E., Lim S.G., Hong W. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clinical and Diagnostic Laboratory Immunology 2004, 11:362-371.
37. Tang X.L., Peppler M.S., Irvin R.T., Suresh M.R. Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertussis. Clinical and Diagnostic Laboratory Immunology 2004, 11:752-757.
38. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 1979, 76:4350-4354.
39. Tripet B., Howard M.W., Jobling M., Holmes R.K., Holmes K.V., Hodges R.S. Structural characterization of the SARS-coronavirus spike S fusion protein core. Journal of Biological Chemistry 2004, 279:20836-20849.
40. Wang Q., Li C., Zhang Q., Wang T., Li J., Guan W., Yu J., Liang M., Li D. Interactions of SARS coronavirus nucleocapsid protein with the host cell proteasome subunit p42. Virology Journal 2010, 17:1-8.
41. Woo P.C., Lau S.K., Wong B.H., Tsoi H.W., Fung A.M., Kao R.Y., Chan K.H., Peiris J.S., Yuen K.Y. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. Journal of Clinical Microbiology 2005, 43:3054-3058.
42. Xiao X., Chakraborti S., Dimitrov A.S., Gramatikoff K., Dimitrov D.S. The SARS-CoV S glycoprotein: expression and functional characterization. Biochemical and Biophysical Research Communications 2003, 312:1159-1164.
43. Yang X.H., Deng W., Tong Z., Liu Y.X., Zhang L.F., Zhu H., Gao H., Huang L., Liu Y.L., Ma C.M., Xu Y.F., Ding M.X., Deng H.K., Qin C. Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comparative Medicine 2007, 57:450-459.
44. Ying W., Hao Y., Zhang Y., Peng W., Qin E., Cai Y., Wei K., Wang J., Chang G., Sun W., Dai S., Li X., Zhu Y., Li J., Wu S., Guo L., Dai J., Wang J., Wan P., Chen T., Du C., Li D., Wan J., Kuai X., Li W., Shi R., Wei H., Cao C., Yu M., Liu H., Dong F., Wang D., Zhang X., Qian X., Zhu Q., He F. Proteomic analysis on structural proteins of severe acute respiratory syndrome coronavirus. Proteomics 2004, 4:492-504.
45. Yip C.W., Hon C.C., Shi M., Lam T.T., Chow K.Y., Zeng F., Leung F.C. Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses. Infection, Genetics and Evolution 2009, 9:1185-1196.
46. Yu F., Le M.Q., Inoue S., Hasebe F., Parquet, Mdel C., Morikawa S., Morita K. Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of severe acute respiratory syndrome coronavirus infection. Clinical and Vaccine Immunology 2007, 14:146-149.
47. Yuan J., Hon C.C., Li Y., Wang D., Xu G., Zhang H., Zhou P., Poon L.L., Lam T.T., Leung F.C., Shi Z. Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. Journal of General Virology 2010, 91:1058-1062.
48. Zhou T., Wang H., Luo D., Rowe T., Wang Z., Hogan R.J., Qiu S., Bunzel R.J., Huang G., Mishra V., Voss T.G., Kimberly R., Luo M. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies. Journal of Virology 2004, 78:7217-7226.